LEERINK PARTNERS
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital markets and investment objectives. They partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare.
LEERINK PARTNERS
Industry:
Banking Health Care
Founded:
1995-01-01
Status:
Active
Contact:
(800) 808-7525
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SSL By Default Font Awesome Apache ReCAPTCHA Microsoft GoDaddy SSL Gravity Forms IIS 8 ASP.NET Ajax Google Maps For Work
Similar Organizations
Accelerator Group
Accelerator Group is an investment banking Advisory services and Knowledge Services firm.
Macquarie Group
Macquarie Group is a global provider of banking, financial, advisory, investment and funds management services.
Moda Health
Moda Health offers quality health coverage in Oregon, Washington, and Alaska.
Current Advisors List
Current Employees Featured
Founder
Investors List
Lovell Minnick Partners
Lovell Minnick Partners investment in Private Equity Round - Leerink Partners
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-08-26 | Kinnate Biopharma | Leerink Partners investment in Series C - Kinnate Biopharma | 98 M USD |
| 2019-05-23 | AlloVir | Leerink Partners investment in Series B - AlloVir | 120 M USD |
| 2018-09-05 | Fulcrum Therapeutics | Leerink Partners investment in Series B - Fulcrum Therapeutics | 80 M USD |
| 2018-06-08 | Precision BioSciences | Leerink Partners investment in Series B - Precision BioSciences | 110 M USD |
| 2018-05-16 | FogPharma | Leerink Partners investment in Series B - FogPharma | 66 M USD |
| 2018-02-27 | Generation Bio | Leerink Partners investment in Series B - Generation Bio | 100 M USD |
| 2018-02-01 | Avrobio | Leerink Partners investment in Series B - Avrobio | 60 M USD |
| 2017-11-13 | Arcus Biosciences | Leerink Partners investment in Series C - Arcus Biosciences | 107 M USD |
| 2017-09-08 | Replimune Group | Leerink Partners investment in Series B - Replimune Group | 55 M USD |
| 2017-03-30 | Solid Biosciences | Leerink Partners investment in Series C - Solid Biosciences | 50 M USD |
Newest Events participated
Participated in 3rd Annual NEVY Awards
on 2015-05-13 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-14 | Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer |